We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Roche Holding Ag | LSE:0QQ6 | London | Ordinary Share | CH0012032113 | ROCHE HOLDING ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 58.72B | 11.5B | - | - |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
15:49:35 | O | 22 | 304.00 | CHF |
Date | Time | Source | Headline |
---|---|---|---|
30/1/2025 | 06:00 | UKREG | [Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024.. |
30/1/2025 | 06:00 | UKREG | [Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche erzielt starkes Jahresergebnis.. |
29/1/2025 | 06:00 | UKREG | Change to the Roche Enlarged Corporate Executive Committee |
28/1/2025 | 06:00 | UKREG | Roche’s Itovebi demonstrated statistically significant and clinically.. |
27/1/2025 | 06:00 | UKREG | Roche announces new results from EMBARK demonstrating significant sustained.. |
22/1/2025 | 06:00 | UKREG | Roche receives FDA clearance with CLIA waiver for cobas® liat molecular.. |
08/1/2025 | 06:10 | UKREG | Roche purchases shares in tender offer for Poseida Therapeutics, Inc. |
19/12/2024 | 06:00 | UKREG | Roche’s Phase IIb study of prasinezumab missed primary endpoint, but.. |
18/12/2024 | 06:00 | UKREG | Roche transforms mass spectrometry diagnostics with launch of cobas® Mass.. |
13/12/2024 | 06:10 | UKREG | Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three.. |
Roche (0QQ6) Share Charts1 Year Roche Chart |
|
1 Month Roche Chart |
Intraday Roche Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
15:49:35 | 304.00 | 22 | 0.00 | O |
15:48:56 | 303.80 | 52 | 0.00 | O |
15:40:21 | 304.20 | 40 | 0.00 | O |
15:16:37 | 305.00 | 50 | 0.00 | O |
14:59:00 | 304.20 | 30 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions